Feb 21 (Reuters) - Eyegate Pharmaceuticals Inc EYEG.O
* Eyegate Pharmaceuticals Inc - under license agreement, Valeant will pay company an upfront payment of $4.0 million - SEC filing
* Eyegate Pharmaceuticals Inc - under agreement, company is eligible to receive milestone payments totaling up to approximately $99.0 million Source text: Further company coverage: EYEG.O